Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)

Withdrawn before enrolling

Conditions studied: Cataract, Pseudophakia

In brief

The objective of this investigator initiated study (IIT-002) is to collect data on commercial patients implanted with the RxSight Light Adjustable Lens (LAL).

Key facts

Study ID

NCT06488066

Run by

Vance Thompson Vision

People needed

0

Starts

2021-08-13

Expected to finish

2022-01-01

Last updated by the study team

2024-07-05

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Sign a written Informed Consent Document
• Implanted commercially with the LAL and completed LDD light treatments

You may not qualify if…

• Previous corneal or intraocular surgery other than removal of cataract and implantation of the LAL

Where it is running

• Vance Thompson Vision — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.